Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.

Alcon’s ALC Surgical business continues to gain from its diverse portfolio and incremental innovation. Within Vision Care, the company is registering solid growth, banking on strong sales of its ...

About 90% of patients see better after surgery, says a top eye expert. Here's what experts say about the best timing for ...

Hunter Biden has said he is discontinuing his lawsuit against a former aide to Donald Trump because of his severe financial difficulties. The son of former US president Joe Biden launched a legal ...

(MENAFN- Edelman) Jeddah, March 5, 2025 – Alcon, the global leader in eye care dedicated to helping people see brilliantly, proudly announces the opening of the Alcon Experience Center (AEC ...

Alcon’s advanced lenses, including toric and multi-focal modalities, continue to gain market share. Ocular Health continues to report strong performance with its portfolio of eye drops ...

Alcon’s advanced lenses, including toric and multi-focal modalities, continue to gain market share. Ocular Health continues to report strong performance with its portfolio of eye drops, including ...

Alcon, Inc. ALC delivered fourth-quarter 2024 ... primarily driven by the portfolio of eye drops, including continued strength from the Systane family of artificial tears. However, this was ...

Alcon, which produces contact lenses, eye drops and other related products, said its sales rose 6% in constant currency to $2.4 billion in the final quarter of 2024, matching analysts' estimates ...